Short Interest in Afya Limited (NASDAQ:AFYA) Grows By 8.5%

Afya Limited (NASDAQ:AFYA) saw a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 1,070,000 shares, a growth of 8.5% from the November 15th total of 986,000 shares. Based on an average daily trading volume, of 128,600 shares, the short-interest ratio is presently 8.3 days. Approximately 7.5% of the shares of the company are sold short.

Afya Trading Down 0.2 %

Shares of AFYA stock opened at $15.64 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.60 and a quick ratio of 1.60. The company has a market cap of $1.47 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 0.33 and a beta of 0.89. Afya has a 1 year low of $15.28 and a 1 year high of $22.48. The firm has a fifty day moving average price of $16.65 and a 200-day moving average price of $16.97.

Institutional Trading of Afya

Several hedge funds have recently bought and sold shares of the stock. Renaissance Technologies LLC raised its stake in shares of Afya by 19.7% in the second quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock worth $4,704,000 after buying an additional 43,800 shares during the period. Point72 Asset Management L.P. purchased a new stake in Afya in the 3rd quarter worth approximately $842,000. Erste Asset Management GmbH bought a new stake in Afya during the 3rd quarter worth approximately $822,000. Millennium Management LLC lifted its holdings in Afya by 45.0% during the second quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock valued at $5,139,000 after purchasing an additional 90,383 shares in the last quarter. Finally, Cubist Systematic Strategies LLC boosted its position in shares of Afya by 136.9% in the second quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock worth $622,000 after purchasing an additional 20,370 shares during the period. Institutional investors own 88.02% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on AFYA. The Goldman Sachs Group began coverage on shares of Afya in a research report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 target price for the company. UBS Group started coverage on Afya in a report on Friday, August 30th. They issued a “neutral” rating and a $19.50 target price on the stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.